According to Gram Research analysis, pancreatic enzymes and bile acids do not reduce death rates in severely malnourished, hospitalized children. A 2026 randomized controlled trial of 429 children found that 16-18% died in treatment groups compared to 15-17% in placebo groups, no meaningful difference. The study was stopped early when it became clear these supplements weren’t helping, suggesting doctors should focus on proven interventions like adequate nutrition and infection control instead.
Researchers tested whether two digestive supplements could help save the lives of severely malnourished children in hospitals across Africa and Asia. The study involved 429 children and tested pancreatic enzymes and bile acids, substances that help digest food and fight bacteria in the stomach. After following children for 60 days, the researchers found that neither supplement reduced deaths or improved recovery compared to placebo. The findings suggest doctors need to try different approaches to help this vulnerable group of children survive serious illness.
Key Statistics
A 2026 randomized controlled trial of 429 severely malnourished children found that pancreatic enzymes did not reduce 60-day mortality, with 16% dying in the treatment group versus 17% in the placebo group.
In the same 2026 study across six hospitals in four countries, bile acids showed no mortality benefit, with 18% of treated children dying compared to 15% receiving placebo.
The 2026 trial found that children receiving bile acids spent fewer days on second-line antibiotics, but this single benefit was insufficient to justify using the supplements as routine treatment for severe malnutrition.
The Quick Take
- What they studied: Whether giving severely malnourished, hospitalized children two digestive supplements (pancreatic enzymes and bile acids) could reduce death rates and improve recovery
- Who participated: 429 children ages 2-59 months (roughly 2 months to 5 years old) who were hospitalized with serious illness and severe malnutrition in hospitals in Bangladesh, Kenya, Malawi, and Uganda
- Key finding: Neither pancreatic enzymes nor bile acids reduced death rates. About 16-18% of children died in both treatment and placebo groups, showing no meaningful difference between the groups
- What it means for you: If your child is severely malnourished and hospitalized, these specific supplements won’t improve survival chances. Doctors need to focus on other proven treatments like proper nutrition and infection control
The Research Details
This was a rigorous double-blind randomized controlled trial, meaning neither the doctors nor the families knew which children received the real supplements and which received fake ones (placebos). Children were randomly assigned to four groups: pancreatic enzymes only, bile acids only, both supplements, or placebos for all. The study took place across six hospitals in four countries between June 2021 and October 2022.
The researchers chose these supplements because theory suggested they might help. Severely malnourished children often have weak digestive systems and damaged intestines. The supplements were designed to improve digestion and prevent harmful bacteria from crossing the intestinal barrier into the bloodstream, a condition called bacterial translocation that can cause death. Children received the supplements or placebos for 21 days while hospitalized.
Researchers tracked whether children survived 60 days after starting treatment, how many days they had diarrhea, whether they needed stronger antibiotics, and how their weight and growth changed. This comprehensive approach allowed them to measure multiple ways the supplements might help.
This study design is considered the gold standard for testing whether treatments work. By randomly assigning children and using placebos, researchers eliminated bias and could fairly compare outcomes. Testing in six hospitals across four countries means the results apply to different populations and healthcare settings, making the findings more reliable than a single-hospital study
This trial was well-designed with several strengths: it was registered before starting (preventing researchers from changing results), it included a large number of children across multiple countries, and it used proper statistical methods. The study was stopped early when it became clear the supplements weren’t working, a sign of scientific integrity. However, the study was conducted in low-income countries with limited resources, so results may not apply everywhere. The relatively small sample size for some comparisons means some secondary findings may be less reliable
What the Results Show
The main finding was clear: pancreatic enzymes did not reduce death rates. In the pancreatic enzyme group, 16% of children died by day 60 compared to 17% in the placebo group, essentially identical. Bile acids also showed no benefit, with 18% mortality in the treatment group versus 15% in the placebo group. These small differences could easily occur by chance.
When researchers looked at children who received both supplements together, neither combination worked better than placebo alone. The study was stopped early because it became obvious the supplements weren’t helping, and continuing would be unethical.
For secondary outcomes, the supplements made almost no difference. Children in both groups had similar numbers of days with diarrhea, similar rates of serious side effects, and similar hospital stays. The only small benefit found was that children receiving bile acids needed fewer days of second-line antibiotics (stronger drugs used when first-line antibiotics fail), but this single finding doesn’t justify using the supplements.
Researchers examined several other health measures. Serious adverse events (severe side effects) occurred at similar rates in treatment and placebo groups, suggesting the supplements were safe but ineffective. The number of days children experienced diarrhea was similar across all groups. Children’s weight gain and growth measurements from enrollment to day 21 and day 60 showed no meaningful differences between groups. The duration of initial hospitalization was comparable. These consistent null findings across multiple measures strengthen the conclusion that these supplements simply don’t help this population
This research challenges earlier assumptions based on laboratory studies. Previous research showed that pancreatic enzymes and bile acids have antibacterial properties in test tubes and animal studies, leading researchers to hypothesize they might prevent bacterial translocation in malnourished children. However, this real-world trial in actual patients found no benefit. This gap between laboratory promise and clinical reality is common in medicine and highlights why testing in real patients is essential. The findings suggest that while these substances work in controlled lab settings, the complex biology of severely malnourished children’s bodies may prevent them from being effective
The study had several limitations worth noting. While 429 children is a reasonable sample size, it may not be large enough to detect very small benefits. The study was conducted in low-income countries with limited healthcare resources, so results might differ in wealthier settings with better baseline care. Researchers couldn’t measure bacterial translocation directly, they assumed it was happening based on theory. The study only tested these two specific supplements; other combinations or doses might theoretically work differently. Finally, the study focused on acutely ill children with severe malnutrition; results may not apply to less severely malnourished children or those with different illnesses
The Bottom Line
High confidence: Pancreatic enzymes and bile acids should not be used as routine treatments for severely malnourished, hospitalized children based on this evidence. Instead, focus on proven interventions: adequate nutrition, infection prevention, and appropriate antibiotics when needed. Moderate confidence: Future research should test packages of multiple interventions targeting different aspects of malnutrition rather than single supplements
Healthcare workers and parents of severely malnourished children in hospitals should know these supplements won’t improve survival. Researchers and public health officials should use these findings to redirect resources toward proven interventions. This study is less relevant for mildly or moderately malnourished children or those in wealthy countries with different healthcare systems
The study measured outcomes over 60 days, so any benefits would have appeared within that timeframe. Since no benefits appeared, starting these supplements won’t lead to faster recovery or better outcomes
Frequently Asked Questions
Can pancreatic enzymes help severely malnourished children survive hospitalization?
No. A 2026 trial of 429 hospitalized children found pancreatic enzymes did not reduce death rates compared to placebo. Mortality was 16% with enzymes versus 17% without, showing no meaningful benefit.
Do bile acids improve outcomes in malnourished sick children?
No. The same 2026 study found bile acids did not reduce mortality (18% versus 15% with placebo) or improve other health measures. Only a minor reduction in antibiotic days was observed.
What should doctors give severely malnourished children instead of these supplements?
Focus on proven interventions: adequate nutrition with sufficient calories and protein, infection prevention through hygiene, and appropriate antibiotics when infections occur. These address root causes rather than unproven supplements.
Why did researchers stop this study early?
The study was stopped early because it became clear the supplements weren’t working. Continuing would be unethical, giving some children ineffective treatments while others received placebos when neither helped.
Could these supplements work better at different doses?
This study tested specific doses that seemed reasonable based on theory. Different doses might theoretically work differently, but the current evidence doesn’t support using these supplements at any dose for this population.
Want to Apply This Research?
- If caring for a malnourished child, track daily weight (in grams if possible), days with diarrhea, and antibiotic use. This data helps healthcare providers assess whether nutrition and infection management are working
- Focus app reminders on proven interventions: ensuring adequate calorie and protein intake, maintaining hygiene to prevent infections, and completing prescribed antibiotics as directed, rather than seeking unproven supplements
- Use the app to monitor recovery progress through weight gain, reduced diarrhea frequency, and decreased need for antibiotics over weeks and months. These practical measures indicate improving health better than any single supplement
This research applies specifically to severely malnourished children hospitalized with acute illness in low-income countries. These findings should not be interpreted as medical advice. Parents and healthcare providers should consult with qualified medical professionals before making treatment decisions for individual children. While this study found no benefit from these supplements, other treatments and interventions may be appropriate depending on each child’s specific condition. This summary is for educational purposes and does not replace professional medical judgment.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.
